CN105410596A - 一种薏仁糊及其制作方法 - Google Patents
一种薏仁糊及其制作方法 Download PDFInfo
- Publication number
- CN105410596A CN105410596A CN201510715267.3A CN201510715267A CN105410596A CN 105410596 A CN105410596 A CN 105410596A CN 201510715267 A CN201510715267 A CN 201510715267A CN 105410596 A CN105410596 A CN 105410596A
- Authority
- CN
- China
- Prior art keywords
- heart
- paste
- barley
- lotus
- lotus seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 235000007340 Hordeum vulgare Nutrition 0.000 title abstract 8
- 240000005979 Hordeum vulgare Species 0.000 title 1
- 238000003756 stirring Methods 0.000 claims abstract description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 13
- 244000268590 Euryale ferox Species 0.000 claims abstract description 13
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 239000012535 impurity Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 32
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 32
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 32
- 239000002245 particle Substances 0.000 claims description 25
- 244000077995 Coix lacryma jobi Species 0.000 claims description 14
- 241000209205 Coix Species 0.000 claims description 13
- 235000007354 Coix lacryma jobi Nutrition 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 6
- 235000013339 cereals Nutrition 0.000 claims description 5
- 239000010419 fine particle Substances 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 11
- 235000013305 food Nutrition 0.000 abstract description 9
- 206010012735 Diarrhoea Diseases 0.000 abstract description 5
- 206010030113 Oedema Diseases 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 238000002560 therapeutic procedure Methods 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 201000009053 Neurodermatitis Diseases 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 208000007502 anemia Diseases 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 abstract description 2
- 208000002894 beriberi Diseases 0.000 abstract description 2
- 241000209219 Hordeum Species 0.000 abstract 7
- 241001247821 Ziziphus Species 0.000 abstract 3
- 206010006895 Cachexia Diseases 0.000 abstract 1
- 208000007514 Herpes zoster Diseases 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 208000026500 emaciation Diseases 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000012545 processing Methods 0.000 abstract 1
- -1 sterol ester Chemical class 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 4
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 4
- OALYTRUKMRCXNH-UHFFFAOYSA-N 5-pentyloxolan-2-one Chemical compound CCCCCC1CCC(=O)O1 OALYTRUKMRCXNH-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 230000003356 anti-rheumatic effect Effects 0.000 description 3
- 239000003435 antirheumatic agent Substances 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 229960004232 linoleic acid Drugs 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 2
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 2
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 2
- 229940031016 ethyl linoleate Drugs 0.000 description 2
- 229940067592 ethyl palmitate Drugs 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000002759 monoacylglycerols Chemical class 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940098695 palmitic acid Drugs 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 229960004274 stearic acid Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-KHPPLWFESA-N (z)-octadec-8-enoic acid Chemical compound CCCCCCCCC\C=C/CCCCCCC(O)=O WRIDQFICGBMAFQ-KHPPLWFESA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 2,3-Dihydroxypropyl oleate Natural products CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010064390 Tumour invasion Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000003171 anti-complementary effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 230000009400 cancer invasion Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- OALYTRUKMRCXNH-QMMMGPOBSA-N gamma-Nonalactone Natural products CCCCC[C@H]1CCC(=O)O1 OALYTRUKMRCXNH-QMMMGPOBSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种薏仁糊及其制作方法,按重量份计,由以下原料组成:薏仁粉90-110份、山药0.4-0.8份、芡实0.2-0.6份、红枣1.0-1.4份。其制备方法包括选料、除杂、配料、炮制、研磨、搅拌、冷却等步骤。本发明选用的薏仁适宜于病后体弱患者,脚气病、带状孢疹、神经性皮炎患者,适宜消瘦,免疫力低,记忆力下降贫血,水肿等症状的人群。具有抗癌、利水渗湿、祛风湿清、热排脓、健脾止泻等食用疗效。其余成分,山药、芡实和红枣都是具有不错食疗效果的作物果实,在薏仁糊中加入微量的山药、芡实和红枣,可以使薏仁糊更具有应用价值和食疗效果。
Description
技术领域
本发明属于食品技术领域,具体涉及一种薏仁糊,同时还涉及其制作方法。
背景技术
研究发现,薏仁中富含薏苡仁酯(coixenolide),粗蛋白13%-14%,脂类2%-8%。脂类中三酰甘油61%-64%,二酰甘油6%-7%,一酰甘油4%,甾醇酯9%,游离脂肪酸17%-18%。在三酰甘油中亚油酸(linoleicacid)含量可达25%-28%,在游离脂肪酸中亚油酸含量为27%-28%,游离脂肪酸还有棕榈酸(palmiticacid),硬脂酸(stearicacid),顺-8-十八碳烯酸(cis-8-oc-tadecenoicacid)即油酸等。一酰甘油中有具搞肿瘤作用的α-单油酸甘油酯(α-monoolein),甾醇酯中有具促排卵作用的顺-、反-阿魏酰豆甾醇(cis-、trans-feruloylstigmasterol)和顺-、反-阿魏酰菜油甾醇(cis-、trans-feruloylcampesterol)等。还含抗补体作用的葡聚糖和酸性多糖CA-1、CA-2及降血糖作用的薏苡多糖(coixan)A、B、C。种子挥发油含69种成分,其中主要的有已醛(hexanal),已酸(hexanoicacid),2-乙基-3-羟基丁酸已酯(2-ethyl-3-hydroxy-hexylbutrate),γ-壬内酯(γ-nonalactone),壬酸(nonanoicacid),辛酸(octanoicaid),棕榈酸乙酯(ethylpalmitate),亚油酸甲酯(methyllinoleate),香草醛(vanillin)及亚油酸乙酯(ethyllinoleate)等。
1.薏米因含有多种维生素和矿物质,有促进新陈代谢和减少胃肠负担的作用,可作为病中或病后体弱患者的补益食品。
2.经现代药理研究证明,薏米有防癌的作用,其抗癌的有效成分中包括硒元素,能有效抑制癌细胞的增殖,可用于胃癌、子宫颈癌的辅助治疗。
3.薏米中含有一定的维生素E,是一种美容食品,常食可以保持人体皮肤光泽细腻,消除粉刺、色斑,改善肤色,并且它对于由病毒感染引导起的赘疣等有一定的治疗作用。
4.薏米中含有丰富的维生素B,对防治脚气病十分有益。
5、富含碳水化合物,构成机体的重要物质,储存和提供热能。
6、富含脂肪,维持体温和保护内脏;提供必需脂肪酸,促进这些脂溶性维生素的吸收。
7、富含蛋白质,具有维持钾钠平衡,消除水肿。
适宜人群:病后体弱患者,脚气病、带状孢疹、神经性皮炎患者,适宜消瘦,免疫力低,记忆力下降贫血,水肿等症状的人群。
食疗效果:1、抗癌:近年来,大量的科学研究和临床实践证明,薏米还是一种抗癌药物,初步鉴定,它对癌症的抑制率可达35%以上。难怪桂林地区有首民谣这样唱道:"薏米胜过灵芝草,药用营养价值高,常吃可以延年寿,返老还童立功劳。"健康人常吃薏米,能使身体轻捷,减少肿瘤发病几率。
2、利水渗湿:有渗利水湿作用,用于水肿、小便不利、湿毒脚气等病症。
3、祛风湿:能祛风湿,除痹痛,可通利关节,缓解拘挛。用于风湿热痹、关节疼痛。
4、清热排脓:用于肺痈,常配苇茎、冬瓜仁、桃仁,可促进脓痰排出。用于肠痈,常配丹皮、白花蛇舌草等。
5、健脾止泻:本品炒熟能健脾止泻,用于脾虚夹湿之泄泻。
发明内容
本发明的目的在于提供一种食用方便、营养价值丰富的薏仁糊。
本发明的另一目的在于提供该薏仁糊的制作方法。
本发明一种薏仁糊,按重量份计,由以下原料组成:薏仁粉90-110份、山药0.4-0.8份、芡实0.2-0.6份、红枣1.0-1.4份。
本发明一种薏仁糊的制作方法,包括以下步骤:
(1)选料:将薏仁米原粮脱壳处理,优选出优质薏仁颗粒;
(2)除杂:将优选后的薏仁颗粒通过振动选料机去除细小颗粒及薏仁中的杂质;
(3)配料:称取薏仁颗粒90-110份、加入0.4-0.8份的山药、0.2-0.6份的芡实、1.0-1.4份的红枣;
(4)炮制:将配好料的薏仁颗粒混合料放入炮制机中,分两次炮制处理:第一次:在100-140℃温度下,充分炮制20-60分钟;第二次:在60-100℃温度下,充分炮制10-30分钟;
(5)研磨:将炮制好的薏仁颗粒混合料放入磨粉机充分研磨细化;
(6)搅拌:将研磨好的细粉放入搅拌器充分搅拌;
(7)冷却:将经过搅拌的细粉放入冷却盘,放入常温净化室冷却至自然状态。
本发明与现有技术相比,具有明显有益效果,从以上技术方案可知:本发明选用薏仁粉、山药、芡实、红枣为原料。选用的薏仁适宜于病后体弱患者,脚气病、带状孢疹、神经性皮炎患者,适宜消瘦,免疫力低,记忆力下降贫血,水肿等症状的人群,具有抗癌、利水渗湿、祛风湿清、热排脓、健脾止泻等食用疗效。山药、芡实和红枣都是具有不错食疗效果的作物果实,在薏仁糊中加入微量的山药、芡实和红枣,可以使薏仁糊更具有应用价值和食疗效果。本发明富含丰富的营养价值,食疗特性俱佳,食用方便。
具体实施方式
实施例1:
本发明一种薏仁糊的制作方法,包括以下步骤:
(1)选料:将薏仁米原粮脱壳处理,优选出优质薏仁颗粒;
(2)除杂:将优选后的薏仁颗粒通过振动选料机去除细小颗粒及薏仁中的杂质;
(3)配料:称取薏仁颗粒90kg、加入0.8kg的山药、0.2kg的芡实、1.4kg的红枣;
(4)炮制:将配好料的薏仁颗粒混合料放入炮制机中,分两次炮制处理:
第一次:在140℃温度下,充分炮制60分钟;第二次:在60℃温度下,充分炮制10分钟;
(5)研磨:将炮制好的薏仁颗粒混合料放入磨粉机充分研磨细化;
(6)搅拌:将研磨好的细粉放入搅拌器充分搅拌;
(7)冷却:将经过搅拌的细粉放入冷却盘,放入常温净化室冷却至自然状态。
实施例2:
本发明一种薏仁糊的制作方法,包括以下步骤:
(1)选料:将薏仁米原粮脱壳处理,优选出优质薏仁颗粒;
(2)除杂:将优选后的薏仁颗粒通过振动选料机去除细小颗粒及薏仁中的杂质;
(3)配料:称取薏仁颗粒100kg、加入0.6的山药、0.4kg的芡实、1.2kg的红枣;
(4)炮制:将配好料的薏仁颗粒混合料放入炮制机中,分两次炮制处理:
第一次:在120℃温度下,充分炮制40分钟;第二次:在80℃温度下,充分炮制20分钟;
(5)研磨:将炮制好的薏仁颗粒混合料放入磨粉机充分研磨细化;
(6)搅拌:将研磨好的细粉放入搅拌器充分搅拌;
(7)冷却:将经过搅拌的细粉放入冷却盘,放入常温净化室冷却至自然状态。
实施例3:
本发明一种薏仁糊的制作方法,包括以下步骤:
(1)选料:将薏仁米原粮脱壳处理,优选出优质薏仁颗粒;
(2)除杂:将优选后的薏仁颗粒通过振动选料机去除细小颗粒及薏仁中的杂质;
(3)配料:称取薏仁颗粒110kg、加入0.4kg的山药、0.6kg的芡实、1.0kg的红枣;
(4)炮制:将配好料的薏仁颗粒混合料放入炮制机中,分两次炮制处理:
第一次:在100℃温度下,充分炮制20分钟;第二次:在100℃温度下,充分炮制30分钟;
(5)研磨:将炮制好的薏仁颗粒混合料放入磨粉机充分研磨细化;
(6)搅拌:将研磨好的细粉放入搅拌器充分搅拌;
(7)冷却:将经过搅拌的细粉放入冷却盘,放入常温净化室冷却至自然状态。
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,任何未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明技术方案的范围内。
Claims (3)
1.一种薏仁糊,按重量份计,由以下原料组成:
薏仁粉90-110份、山药0.4-0.8份、芡实0.2-0.6份、红枣1.0-1.4份。
2.一种薏仁糊的制作方法,包括以下步骤:
(1)选料:将薏仁米原粮脱壳处理,优选出优质薏仁颗粒;
(2)除杂:将优选后的薏仁颗粒通过振动选料机去除细小颗粒及薏仁中的杂质;
(3)配料:称取薏仁颗粒90-110份、加入0.4-0.8份的山药、0.2-0.6份的芡实、1.0-1.4份的红枣;
(4)炮制:将配好料的薏仁颗粒混合料放入炮制机中,分两次炮制处理;
(5)研磨:将炮制好的薏仁颗粒混合料放入磨粉机充分研磨细化;
(6)搅拌:将研磨好的细粉放入搅拌器充分搅拌。
3.如权利要求2所述的一种薏仁糊的制作方法,其特征在于:在步骤(4)中,分两次炮制处理的方法为:第一次:在100-140℃温度下,充分炮制20-60分钟;第二次:在60-100℃温度下,充分炮制10-30分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510715267.3A CN105410596A (zh) | 2015-10-29 | 2015-10-29 | 一种薏仁糊及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510715267.3A CN105410596A (zh) | 2015-10-29 | 2015-10-29 | 一种薏仁糊及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105410596A true CN105410596A (zh) | 2016-03-23 |
Family
ID=55489517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510715267.3A Pending CN105410596A (zh) | 2015-10-29 | 2015-10-29 | 一种薏仁糊及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105410596A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108095069A (zh) * | 2017-12-04 | 2018-06-01 | 千人计划创新药物与食品安全研究院扬州有限公司 | 一种医学用途肿瘤全营养配方食品及其制备方法 |
CN109287919A (zh) * | 2018-08-20 | 2019-02-01 | 广州初品信息科技有限公司 | 一种赤豆薏仁草本膏的配方及制备方法 |
-
2015
- 2015-10-29 CN CN201510715267.3A patent/CN105410596A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108095069A (zh) * | 2017-12-04 | 2018-06-01 | 千人计划创新药物与食品安全研究院扬州有限公司 | 一种医学用途肿瘤全营养配方食品及其制备方法 |
CN109287919A (zh) * | 2018-08-20 | 2019-02-01 | 广州初品信息科技有限公司 | 一种赤豆薏仁草本膏的配方及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101248874B (zh) | 青稞复合营养粉及其制备方法 | |
CN102172269B (zh) | 一种具有美容作用阿胶组合食品 | |
CN103989165B (zh) | 一种刺梨复合维生素c片及其制备方法 | |
CN105661090A (zh) | 一种高蛋白鸡饲料配方及其制备方法 | |
JP6404339B2 (ja) | 月経前症候群及び月経痛緩和の機能を持つ組成物 | |
CN103749982A (zh) | 用于提高产鸡蛋产量的饲料、中药添加剂和制备方法 | |
CN107467497A (zh) | 一种具有抗肥胖保健功能的五谷杂粮食疗组合物及其制备方法 | |
CN108477609A (zh) | 一种牛蒡减肥代餐棒及其制备方法 | |
KR101627837B1 (ko) | 말뼈 추출물과 해마를 주성분으로 포함하는 건강보조식품 및 그의 제조방법 | |
KR20120003693A (ko) | 적포도 추출물, 녹차 추출물, 대두 추출물 및 l-카르니틴을 유효성분으로 함유하는 항비만 조성물 | |
CN106723068A (zh) | 一种海参番茄红素硒抗辐射胶囊配方及其制备工艺 | |
CN105661031A (zh) | 一种高蛋白鸡饲料配方及其制备方法 | |
CN105410596A (zh) | 一种薏仁糊及其制作方法 | |
CN112205557A (zh) | 一种降血脂药食物质固体饮料及其制备方法 | |
KR20110105627A (ko) | 누에 체액을 함유하는 항비만 조성물 | |
CN105495603A (zh) | 一种高丽红参山楂细胞破壁超微粉的制备方法 | |
KR20120066380A (ko) | 사슴뼈의 분말을 이용한 한방 건강보조식품 | |
JP6541061B2 (ja) | 時計遺伝子発現促進用組成物 | |
CN103005467A (zh) | 一种保肝营养组合物及其保肝营养食品 | |
CN105638961A (zh) | 一种含有苎麻叶的黑茶组合物及制备方法 | |
Selvaraj et al. | Virgin coconut oil: A nutraceutical and therapeutic food | |
CN105661496A (zh) | 一种高丽红参白芷细胞破壁超微粉的制备方法 | |
CN105167013A (zh) | 一种榛子粕为原料制备的保健食品及工艺 | |
CN105053403A (zh) | 甘草牛蒡茶 | |
KR101819920B1 (ko) | 항당뇨 및 항염증 활성을 갖는 꾸지뽕 추출물 함유 발효발아현미 조성물의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160323 |
|
WD01 | Invention patent application deemed withdrawn after publication |